Ligand Pharmaceuticals Inc (NASDAQ:LGND)
| 94.51 BATS BZX Real-Time Price As of 3:40pm ET |  +3.96 / +4.37%Today’s Change | 72.57 Today|||52-Week Range 169.98 | -38.81% Year-to-Date |
Latest LGND News | Press Releases
| Sever Your Ties With These 4 Toxic Stocks to Ward Off Losses 7:42am / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 90.55 |
| Today’s open | 92.12 |
| Day’s range | 91.25 - 94.66 |
| Volume | 9,895 |
| Average volume (3 months) | 158,895 |
| Market cap | $1.5B |
Data as of 3:40pm ET, 07/05/2022
Growth & Valuation
| Earnings growth (last year) | -- |
| Earnings growth (this year) | -62.74% |
| Earnings growth (next 5 years) | +15.00% |
| Revenue growth (last year) | +48.66% |
| P/E ratio | 70.0 |
| Price/Sales | 9.61 |
| Price/Book | 1.85 |
Financials
| Next reporting date | August 8, 2022 |
| EPS forecast (this quarter) | $0.43 |
| Annual revenue (last year) | $277.1M |
| Annual profit (last year) | $57.1M |
| Net profit margin | 20.62% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Emeryville, California |
Forecasts
